More on idiopathic pulmonary arterial hypertension with a low diffusing capacity

Eur Respir J. 2017 Aug 3;50(2):1700354. doi: 10.1183/13993003.00354-2017. Print 2017 Aug.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Familial Primary Pulmonary Hypertension / drug therapy
  • Familial Primary Pulmonary Hypertension / mortality
  • Familial Primary Pulmonary Hypertension / physiopathology*
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Phosphodiesterase 5 Inhibitors / therapeutic use
  • Pulmonary Diffusing Capacity*

Substances

  • Phosphodiesterase 5 Inhibitors